Found 0 matching trials
177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors
PHASE2This is a randomized phase II, parallel group study. Patients with gastro-e...
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
PHASE2Assess whether therapy with axitinib, a potent angiogenic inhibitor of the ...
Location
Marburg Universitätsklinikum Giessen und Marburg GmbH
A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs
PHASE3The study is to evaluate the sstr antagonists, 68Ga-DOTATATE and 177Lu-DOTA...
Location
Peking Union Medical College Hospital
Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues
PHASE4Long-term (up to 3 years) clinical and hormonal outcomes in acromegalic pat...
Location
Asan Medical Center
Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy
PHASE2The purpose of this study is to evaluate the safety and tolerability of tel...
Location
Hematology Oncology Services of Arkansas
Pasireotide LAR and Pegvisomant Study in Acromegaly
PHASE4The objective of this study is to assess the efficacy of Pasireotide Long A...
Location
Erasmus Medical Center
Ultrasound Guided Octreotide LAR Injection in Acromegaly
PHASE4Approximately half of patients with acromegaly do not respond to treatment ...
Location
Cedars-Sinai Medical Center
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
PHASE4The morbidity and the mortality in acromegalic patients closely correspond ...
Location
Department of Endocrinology, Odense University Hospital
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
PHASE2Objectives:
Primary endpoint:
-Assess the clinical activity of RAD 001 pl...
Location
UT MD Anderson Cancer Center
Preoperative Octreotide Treatment of Acromegaly
PHASE4The purpose of this study is to investigate whether 6 months preoperative t...
Location
Endocrinology Unit, Department of Medicine, Haukeland University Hospital